Develop guidelines, patient-selection criteria, and methods to protectpatient privacyIn 2002 and beyond, we can expect to change the way we communicate withpatients. A few decades ago, a patient who was sent for blood tests or x-rayswas contacted if the tests were abnormal and asked to call the office in10 to 14 days to review the results with the doctor. This technique wastime consuming, and phone tag was an expensive game for both the pa-tientand the physician.
AUA, SUFU publish 2024 guideline for idiopathic overactive bladder
April 25th 2024“This brand new guideline offers options for all patients with OAB with a focus on shared decision-making between patients with OAB and clinicians, as well as a personalized, tailored approach to care,” said Cameron and Smith.
Enzalutamide granted approval in EU for nmHSPC
April 24th 2024The approval is supported by data from the phase 3 EMBARK trial, which demonstrated that enzalutamide with or without leuprolide prolonged metastasis-free survival compared with leuprolide alone in patients with high-risk biochemically recurrent nmHSPC.